Unexpected Weight Loss? It Could Be Cancer, Says New Research
A study from the Dana-Farber Cancer Institute indicates that unintentional weight loss is linked to a heightened risk of receiving a cancer diagnosis within the…
Dana-Farber Cancer Institute News
Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a world-renowned leader in cancer treatment and research. Established in 1947, the institute is a principal teaching affiliate of Harvard Medical School and serves as a cancer treatment center within the broader Harvard-affiliated hospitals. Dana-Farber is recognized for its commitment to providing cancer patients with the best treatment available while advancing the understanding and treatment of cancer through innovative research. The institute’s research program is one of the largest cancer research enterprises in the world, with a vast array of clinical trials and cutting-edge studies in oncology. Dana-Farber also emphasizes patient care, offering a holistic approach that focuses on both physical and emotional well-being. Its contributions to the development of cancer treatments, such as chemotherapy, targeted therapies, and immunotherapies, have significantly impacted cancer survival rates and quality of life for patients globally.
Princeton Scientists Discover Overlooked Parts of Proteins That Are Critical to Fundamental Functions of Life
Recent research shows that proteins’ intrinsically disordered regions (IDRs) are critical for chromatin regulation and gene expression. Mutations in these IDRs affect cellular functions, especially…
Breakthrough! Receptor “Decoy” Drug Neutralizes COVID-19 Virus Including Omicron and Other Variants
Investigational drug works differently than antibody drugs which are losing effectiveness against the COVID-19 virus. Scientists have developed a drug that potently neutralizes SARS-CoV-2, the…
Harvard Researchers Have Solved a Perplexing Cancer Mystery
A new mechanism links mutations in areas devoid of genes to cancer. For many years, the human genome was seen as a book of life,…
Increased Vitamin D Intake May Protect Against Young-Onset Colorectal Cancer
Consuming higher amounts of Vitamin D – mainly from dietary sources – may help protect against developing young-onset colorectal cancer or precancerous colon polyps, according…
New Evidence Discovered of Health Threat From Chemicals in Tobacco and Marijuana Smoke
Marijuana smoking found to raise levels of potentially harmful chemicals but to a lesser degree than tobacco smoking; Exposure to a toxic chemical associated with…
A Promising New Form of Immunotherapy for Cancer
New research suggests a way to increase the staying power of CAR T cells, a promising form of immunotherapy for cancer. In people with chronic…
Study Shows Vitamin D Protects Against Colorectal Cancer
A newly published study from the Dana-Farber Cancer Institute reveals that vitamin D can protect some people with colorectal cancer by perking up the immune…
Therapeutic Cancer Vaccine Begins Human Clinical Trials
A Phase I clinical trial of an implantable vaccine to treat melanoma has begun. A cross-disciplinary team of scientists, engineers, and clinicians announced today that…
“Personalized” Tumor Vaccine Works on Hard-to-Treat Leukemia
In a newly published study, researchers observed a strong and selective immune response in some patients who received, shortly after the transplant, several doses of…
Highly Recurrent Mutations Discovered in “Dark Matter” of the Cancer Genome
Two newly discovered TERT promoter mutations were found to be even more common than BRAF mutations in melanoma, collectively occurring in 71% of the melanomas…
Study Links Dietary Glycemic Load and Colon Cancer
A newly published study found that a diet heavy in complex sugars and carbohydrate-rich foods is likely to lead to a recurrence of colorectal cancer…
Aspirin Can Extend the Life of Colorectal Cancer Patients
A newly published study shows that aspirin can be effective in prolonging survival among patients whose colorectal cancer tests positive for a mutation in the…
Combined Drug Treatment Delays Resistance in Melanoma Patients
A recent study showed that using the combined treatment of kinase inhibitors dabrafenib and trametinib, while targeting different points in the same growth-factor pathway, delayed…
Beige Fat May Have Therapeutic Potential for Treating Obesity
A team of researchers isolated and determined the unique genetic profile of beige fat for the first time, finding that beige fat is genetically distinct…
Researchers Identify BAD as Key Seizure-Suppressing Protein
New research from the Harvard Medical School and the Dana-Farber Cancer Institute examines why a diet high in fat and low in carbohydrates can reduce…